SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Targeting the HIV Reservoir: Novel Cure Strategies
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
Session Overview
Marina Caskey
The Rockefeller University, New York, NY, USA
Targeting the HIV-1 Latent Reservoir With Tat-CRISPR Lipid Nanoparticles (ABSTRACT
406)
Keely Gliwa
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Bispecific Biologics That Activate Latent HIV-1 Ex Vivo and In Vivo (ABSTRACT
405)
David D. Ho
Aaron Diamond AIDS Research Center, New York, NY, USA
Combination Therapy With Tat mRNA and a TLR9 Agonist Delays Post-ATI Rebound in the NHP Model (ABSTRACT
407)
Takuto Nogimori
National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan
Markedly Reduced Mutability of Networked Epitopes Promotes CTL Clearance of the Latent HIV Reservoir (ABSTRACT
408)
Fernando B. Senjobe
Harvard Medical School, Boston, MA, USA
Discussion With Audience Questions and Answers
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
